Skip to main content
NCBI home page
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 1994 Nov;86(11):839–852.

Common emergencies in cancer medicine: infectious and treatment-related syndromes, Part II.

C R Thomas Jr 1, K J Stelzer 1, J G Douglas 1, W J Koh 1, L V Wood 1, R Panicker 1
PMCID: PMC2607622  PMID: 7807572

Abstract

This article completes a summary of the common medical emergencies that can occur as a result of infectious processes (Part I) and antitumor treatment secondary to chemotherapy, biological response modifiers, or radiotherapy (Part II). The use of high-dose cytotoxic agents, coupled with the common instillation of indwelling central venous access devices, have altered the spectrum of infectious etiologies that are appreciated in clinical practice. In addition, a myriad of cytotoxic agents and radiotherapeutic treatment schemes are used widely in clinical oncologic practice. While most of their related side effects are not considered life-threatening emergencies, they can be fatal if not recognized early and treated promptly. Moreover, some of these infectious and treatment-related sequelae can be prevented. This article highlights some of these clinical observations.

Full text

PDF
839

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASSCHER A. W., ANSON S. G. Arterial hypertension and irradiation damage to the nervous system. Lancet. 1962 Dec 29;2(7270):1343–1346. doi: 10.1016/s0140-6736(62)91020-6. [DOI] [PubMed] [Google Scholar]
  2. Ackland S. P., Schilsky R. L. High-dose methotrexate: a critical reappraisal. J Clin Oncol. 1987 Dec;5(12):2017–2031. doi: 10.1200/JCO.1987.5.12.2017. [DOI] [PubMed] [Google Scholar]
  3. Adamson P. C., Balis F. M., McCully C. L., Godwin K. S., Bacher J. D., Walsh T. J., Poplack D. G. Rescue of experimental intrathecal methotrexate overdose with carboxypeptidase-G2. J Clin Oncol. 1991 Apr;9(4):670–674. doi: 10.1200/JCO.1991.9.4.670. [DOI] [PubMed] [Google Scholar]
  4. Aksoy M., Basu T. K., Brient J., Dickerson J. W. Thiamin status of patients treated with drug combinations containing 5-fluorouracil. Eur J Cancer. 1980 Aug;16(8):1041–1045. doi: 10.1016/0014-2964(80)90251-0. [DOI] [PubMed] [Google Scholar]
  5. Altman A. J., Dinndorf P., Quinn J. J. Acute pancreatitis in association with cytosine arabinoside therapy. Cancer. 1982 Apr 1;49(7):1384–1386. doi: 10.1002/1097-0142(19820401)49:7<1384::aid-cncr2820490714>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  6. Andersson B. S., Luna M. A., Yee C., Hui K. K., Keating M. J., McCredie K. B. Fatal pulmonary failure complicating high-dose cytosine arabinoside therapy in acute leukemia. Cancer. 1990 Mar 1;65(5):1079–1084. doi: 10.1002/1097-0142(19900301)65:5<1079::aid-cncr2820650506>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  7. Andriole G. L., Sandlund J. T., Miser J. S., Arasi V., Linehan M., Magrath I. T. The efficacy of mesna (2-mercaptoethane sodium sulfonate) as a uroprotectant in patients with hemorrhagic cystitis receiving further oxazaphosphorine chemotherapy. J Clin Oncol. 1987 May;5(5):799–803. doi: 10.1200/JCO.1987.5.5.799. [DOI] [PubMed] [Google Scholar]
  8. BERGMANN M., GRAHAM E. A. Pneumonectomy for severe irradiation damage of the lung. J Thorac Surg. 1951 Dec;22(6):549–567. [PubMed] [Google Scholar]
  9. Baekmark U. B. Neurologic complications after irradiation of the cervical spinal cord for malignant tumour of the head and neck. Acta Radiol Ther Phys Biol. 1975 Feb;14(1):33–41. doi: 10.3109/02841867509132259. [DOI] [PubMed] [Google Scholar]
  10. Baker W. J., Royer G. L., Jr, Weiss R. B. Cytarabine and neurologic toxicity. J Clin Oncol. 1991 Apr;9(4):679–693. doi: 10.1200/JCO.1991.9.4.679. [DOI] [PubMed] [Google Scholar]
  11. Banerjee A., Brotherston T. M., Lamberty B. G., Campbell R. C. Cancer chemotherapy agent-induced perivenous extravasation injuries. Postgrad Med J. 1987 Jan;63(735):5–9. doi: 10.1136/pgmj.63.735.5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Blum R. H., Carter S. K., Agre K. A clinical review of bleomycin--a new antineoplastic agent. Cancer. 1973 Apr;31(4):903–914. doi: 10.1002/1097-0142(197304)31:4<903::aid-cncr2820310422>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  13. Cantrell J. E., Jr, Phillips T. M., Schein P. S. Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy. J Clin Oncol. 1985 May;3(5):723–734. doi: 10.1200/JCO.1985.3.5.723. [DOI] [PubMed] [Google Scholar]
  14. Carmel R. J., Kaplan H. S. Mantle irradiation in Hodgkin's disease. An analysis of technique, tumor eradication, and complications. Cancer. 1976 Jun;37(6):2813–2825. doi: 10.1002/1097-0142(197606)37:6<2813::aid-cncr2820370637>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  15. Ceci G., Bella M., Melissari M., Gabrielli M., Bocchi P., Cocconi G. Fatal hepatic vascular toxicity of DTIC. Is it really a rare event? Cancer. 1988 May 15;61(10):1988–1991. doi: 10.1002/1097-0142(19880515)61:10<1988::aid-cncr2820611010>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  16. Cohen M. E., Duffner P. K., Terplan K. L. Myelopathy with severe structural derangement associated with combined modality therapy. Cancer. 1983 Nov 1;52(9):1590–1596. doi: 10.1002/1097-0142(19831101)52:9<1590::aid-cncr2820520909>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  17. Constine L. S., Konski A., Ekholm S., McDonald S., Rubin P. Adverse effects of brain irradiation correlated with MR and CT imaging. Int J Radiat Oncol Biol Phys. 1988 Aug;15(2):319–330. doi: 10.1016/s0360-3016(98)90011-6. [DOI] [PubMed] [Google Scholar]
  18. Daugaard G., Abildgaard U. Cisplatin nephrotoxicity. A review. Cancer Chemother Pharmacol. 1989;25(1):1–9. doi: 10.1007/BF00694330. [DOI] [PubMed] [Google Scholar]
  19. Daugaard G., Abildgaard U., Holstein-Rathlou N. H., Bruunshuus I., Bucher D., Leyssac P. P. Renal tubular function in patients treated with high-dose cisplatin. Clin Pharmacol Ther. 1988 Aug;44(2):164–172. doi: 10.1038/clpt.1988.132. [DOI] [PubMed] [Google Scholar]
  20. DeCosse J. J., Rhodes R. S., Wentz W. B., Reagan J. W., Dworken H. J., Holden W. D. The natural history and management of radiation induced injury of the gastrointestinal tract. Ann Surg. 1969 Sep;170(3):369–384. doi: 10.1097/00000658-196909010-00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. DeFronzo R. A., Braine H., Colvin M., Davis P. J. Water intoxication in man after cyclophosphamide therapy. Time course and relation to drug activation. Ann Intern Med. 1973 Jun;78(6):861–869. doi: 10.7326/0003-4819-78-6-861. [DOI] [PubMed] [Google Scholar]
  22. DeGraw J. I., Brown V. H., Tagawa H., Kisliuk R. L., Gaumont Y., Sirotnak F. M. Synthesis and antitumor activity of 10-alkyl-10-deazaminopterins. A convenient synthesis of 10-deazaminopterin. J Med Chem. 1982 Oct;25(10):1227–1230. doi: 10.1021/jm00352a026. [DOI] [PubMed] [Google Scholar]
  23. Dembo A. J. Abdominopelvic radiotherapy in ovarian cancer. A 10-year experience. Cancer. 1985 May 1;55(9 Suppl):2285–2290. doi: 10.1002/1097-0142(19850501)55:9+<2285::aid-cncr2820551436>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  24. Di Chiro G., Oldfield E., Wright D. C., De Michele D., Katz D. A., Patronas N. J., Doppman J. L., Larson S. M., Ito M., Kufta C. V. Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies. AJR Am J Roentgenol. 1988 Jan;150(1):189–197. doi: 10.2214/ajr.150.1.189. [DOI] [PubMed] [Google Scholar]
  25. Doll D. C., Ringenberg Q. S., Yarbro J. W. Vascular toxicity associated with antineoplastic agents. J Clin Oncol. 1986 Sep;4(9):1405–1417. doi: 10.1200/JCO.1986.4.9.1405. [DOI] [PubMed] [Google Scholar]
  26. Einhorn L., Krause M., Hornback N., Furnas B. Enhanced pulmonary toxicity with bleomycin and radiotherapy in oat cell lung cancer. Cancer. 1976 May;37(5):2414–2416. doi: 10.1002/1097-0142(197605)37:5<2414::aid-cncr2820370533>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  27. Ensley J. F., Patel B., Kloner R., Kish J. A., Wynne J., al-Sarraf M. The clinical syndrome of 5-fluorouracil cardiotoxicity. Invest New Drugs. 1989 Apr;7(1):101–109. doi: 10.1007/BF00178196. [DOI] [PubMed] [Google Scholar]
  28. Epstein J. A., Epstein B. S., Lavine L. S., Carras R., Rosenthal A. D. Cervical myeloradiculopathy caused by arthrotic hypertrophy of the posterior facets and laminae. J Neurosurg. 1978 Sep;49(3):387–392. doi: 10.3171/jns.1978.49.3.0387. [DOI] [PubMed] [Google Scholar]
  29. Freeman N. J., Costanza M. E. 5-Fluorouracil-associated cardiotoxicity. Cancer. 1988 Jan 1;61(1):36–45. doi: 10.1002/1097-0142(19880101)61:1<36::aid-cncr2820610108>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  30. Galland R. B., Spencer J. Surgical management of radiation enteritis. Surgery. 1986 Feb;99(2):133–139. [PubMed] [Google Scholar]
  31. Galland R. B., Spencer J. The natural history of clinically established radiation enteritis. Lancet. 1985 Jun 1;1(8440):1257–1258. doi: 10.1016/s0140-6736(85)92322-0. [DOI] [PubMed] [Google Scholar]
  32. Godwin-Austen R. B., Howell D. A., Worthington B. Observations on radiation myelopathy. Brain. 1975 Dec;98(4):557–568. doi: 10.1093/brain/98.4.557. [DOI] [PubMed] [Google Scholar]
  33. Goldwein J. W. Radiation myelopathy: a review. Med Pediatr Oncol. 1987;15(2):89–95. doi: 10.1002/mpo.2950150208. [DOI] [PubMed] [Google Scholar]
  34. Gradishar W., Vokes E., Schilsky R., Weichselbaum R., Panje W. Vascular events in patients receiving high-dose infusional 5-fluorouracil-based chemotherapy: the University of Chicago experience. Med Pediatr Oncol. 1991;19(1):8–15. doi: 10.1002/mpo.2950190103. [DOI] [PubMed] [Google Scholar]
  35. Grant B. P., Fletcher G. H. Analysis of complications following megavoltage therapy for squamous cell carcinomas of the tonsillar area. Am J Roentgenol Radium Ther Nucl Med. 1966 Jan;96(1):28–36. doi: 10.2214/ajr.96.1.28. [DOI] [PubMed] [Google Scholar]
  36. Green N., Iba G., Smith W. R. Measures to minimize small intestine injury in the irradiated pelvis. Cancer. 1975 Jun;35(6):1633–1640. doi: 10.1002/1097-0142(197506)35:6<1633::aid-cncr2820350624>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  37. Hacker N. F., Berek J. S., Burnison C. M., Heintz P. M., Juillard G. J., Lagasse L. D. Whole abdominal radiation as salvage therapy for epithelial ovarian cancer. Obstet Gynecol. 1985 Jan;65(1):60–66. [PubMed] [Google Scholar]
  38. Harling H., Balslev I. Long-term prognosis of patients with severe radiation enteritis. Am J Surg. 1988 Mar;155(3):517–519. doi: 10.1016/s0002-9610(88)80126-0. [DOI] [PubMed] [Google Scholar]
  39. Harris L. F. Chronic mandibular osteomyelitis. South Med J. 1986 Jun;79(6):696–697. doi: 10.1097/00007611-198606000-00012. [DOI] [PubMed] [Google Scholar]
  40. Harris L. N., Ragaz J. Ventricular arrhythmia and adrenal insufficiency after fluorouracil: new side effects of an old drug. J Natl Cancer Inst. 1993 Feb 17;85(4):326–328. doi: 10.1093/jnci/85.4.326. [DOI] [PubMed] [Google Scholar]
  41. Hart G. B., Mainous E. G. The treatment of radiation necrosis with hyperbaric oxygen (OHP). Cancer. 1976 Jun;37(6):2580–2585. doi: 10.1002/1097-0142(197606)37:6<2580::aid-cncr2820370603>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  42. Honigsberger L., Fielding J. W., Priestman T. J. Neurological effects of recombinant human interferon. Br Med J (Clin Res Ed) 1983 Feb 26;286(6366):719–719. doi: 10.1136/bmj.286.6366.719-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Jao S. W., Beart R. W., Jr, Gunderson L. L. Surgical treatment of radiation injuries of the colon and rectum. Am J Surg. 1986 Feb;151(2):272–277. doi: 10.1016/0002-9610(86)90086-3. [DOI] [PubMed] [Google Scholar]
  44. Jehn U., Göldel N., Rienmüller R., Wilmanns W. Non-cardiogenic pulmonary edema complicating intermediate and high-dose Ara C treatment for relapsed acute leukemia. Med Oncol Tumor Pharmacother. 1988;5(1):41–47. doi: 10.1007/BF03003180. [DOI] [PubMed] [Google Scholar]
  45. Keane T. J., Van Dyk J., Rider W. D. Idiopathic interstitial pneumonia following bone marrow transplantation: the relationship with total body irradiation. Int J Radiat Oncol Biol Phys. 1981 Oct;7(10):1365–1370. doi: 10.1016/0360-3016(81)90032-8. [DOI] [PubMed] [Google Scholar]
  46. Kim Y. H., Fayos J. V. Radiation tolerance of the cervical spinal cord. Radiology. 1981 May;139(2):473–478. doi: 10.1148/radiology.139.2.7220892. [DOI] [PubMed] [Google Scholar]
  47. Kinsella T. J., Bloomer W. D. Tolerance of the intestine to radiation therapy. Surg Gynecol Obstet. 1980 Aug;151(2):273–284. [PubMed] [Google Scholar]
  48. Kirtley D. W., Votaw M. L., Thomas E. Jaundice and hepatorenal syndrome associated with cytosine arabinoside. J Natl Med Assoc. 1990 Mar;82(3):209, 213, 217-8. [PMC free article] [PubMed] [Google Scholar]
  49. Korec S., Schein P. S., Smith F. P., Neefe J. R., Woolley P. V., Goldberg R. M., Phillips T. M. Treatment of cancer-associated hemolytic uremic syndrome with staphylococcal protein A immunoperfusion. J Clin Oncol. 1986 Feb;4(2):210–215. doi: 10.1200/JCO.1986.4.2.210. [DOI] [PubMed] [Google Scholar]
  50. Lammers P. J., White L., Ettinger L. J. Cis-platinum-induced renal sodium wasting. Med Pediatr Oncol. 1984;12(5):343–346. doi: 10.1002/mpo.2950120509. [DOI] [PubMed] [Google Scholar]
  51. Lesesne J. B., Rothschild N., Erickson B., Korec S., Sisk R., Keller J., Arbus M., Woolley P. V., Chiazze L., Schein P. S. Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry. J Clin Oncol. 1989 Jun;7(6):781–789. doi: 10.1200/JCO.1989.7.6.781. [DOI] [PubMed] [Google Scholar]
  52. Litam J. P., Dail D. H., Spitzer G., Vellekoop L., Verma D. S., Zander A. R., Dicke K. A. Early pulmonary toxicity after administration of high-dose BCNU. Cancer Treat Rep. 1981 Jan-Feb;65(1-2):39–44. [PubMed] [Google Scholar]
  53. Littman P., Rosenstock J. G., Bailey C. Radiation myelitis following craniospinal irradiation with concurrent actinomycin-D therapy. Med Pediatr Oncol. 1978;5(1):145–151. doi: 10.1002/mpo.2950050121. [DOI] [PubMed] [Google Scholar]
  54. Lorenzo N. D., Nolletti A., Palma L. Late cerebral radionecrosis. Surg Neurol. 1978 Nov;10(5):281–290. [PubMed] [Google Scholar]
  55. MOERTEL C. G., REITEMEIER R. J., BOLTON C. F., SHORTER R. G. CEREBELLAR ATAXIA ASSOCIATED WITH FLUORINATED PYRIMIDINE THERAPY. Cancer Chemother Rep. 1964 Sep;41:15–18. [PubMed] [Google Scholar]
  56. MOSS W. T., HADDY F. J., SWEANY S. K. Some factors altering the severity of acute radiation pneumonitis: variation with cortisone, heparin, and antibiotics. Radiology. 1960 Jul;75:50–54. doi: 10.1148/75.1.50. [DOI] [PubMed] [Google Scholar]
  57. Margolis L., Smith M. E., Fortuin F. D., Chin F. K., Liebel S. A., Hill D. R. Intramedullary tumor metastasis simulating radiation myelitis: report of a case. Cancer. 1981 Oct 1;48(7):1680–1683. doi: 10.1002/1097-0142(19811001)48:7<1680::aid-cncr2820480734>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  58. Marks J. E., Baglan R. J., Prassad S. C., Blank W. F. Cerebral radionecrosis: incidence and risk in relation to dose, time, fractionation and volume. Int J Radiat Oncol Biol Phys. 1981 Feb;7(2):243–252. doi: 10.1016/0360-3016(81)90443-0. [DOI] [PubMed] [Google Scholar]
  59. Marx R. E. A new concept in the treatment of osteoradionecrosis. J Oral Maxillofac Surg. 1983 Jun;41(6):351–357. doi: 10.1016/s0278-2391(83)80005-6. [DOI] [PubMed] [Google Scholar]
  60. Marx R. E. Osteoradionecrosis: a new concept of its pathophysiology. J Oral Maxillofac Surg. 1983 May;41(5):283–288. doi: 10.1016/0278-2391(83)90294-x. [DOI] [PubMed] [Google Scholar]
  61. Mattson K., Niiranen A., Iivanainen M., Färkkilä M., Bergström L., Holsti L. R., Kauppinen H. L., Cantell K. Neurotoxicity of interferon. Cancer Treat Rep. 1983 Oct;67(10):958–961. [PubMed] [Google Scholar]
  62. McCunniff A. J., Liang M. J. Radiation tolerance of the cervical spinal cord. Int J Radiat Oncol Biol Phys. 1989 Mar;16(3):675–678. doi: 10.1016/0360-3016(89)90484-7. [DOI] [PubMed] [Google Scholar]
  63. McDonald G. B., Hinds M. S., Fisher L. D., Schoch H. G., Wolford J. L., Banaji M., Hardin B. J., Shulman H. M., Clift R. A. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med. 1993 Feb 15;118(4):255–267. doi: 10.7326/0003-4819-118-4-199302150-00003. [DOI] [PubMed] [Google Scholar]
  64. Mittelman A. Life-threatening toxicity of cancer therapy. Crit Care Clin. 1988 Jan;4(1):1–9. [PubMed] [Google Scholar]
  65. Moore D. H., Fowler W. C., Jr, Crumpler L. S. 5-Fluorouracil neurotoxicity. Gynecol Oncol. 1990 Jan;36(1):152–154. doi: 10.1016/0090-8258(90)90127-7. [DOI] [PubMed] [Google Scholar]
  66. Murgo A. J. Thrombotic microangiopathy in the cancer patient including those induced by chemotherapeutic agents. Semin Hematol. 1987 Jul;24(3):161–177. [PubMed] [Google Scholar]
  67. NG E., CHAMBERS F. W., OGDEN H. S., COGGS G. C., CRANE J. T. Osteomyelitis of the mandible following irradiation; an experimental study. Radiology. 1959 Jan;72(1):68–74. doi: 10.1148/72.1.68. [DOI] [PubMed] [Google Scholar]
  68. Olver I. N., Aisner J., Hament A., Buchanan L., Bishop J. F., Kaplan R. S. A prospective study of topical dimethyl sulfoxide for treating anthracycline extravasation. J Clin Oncol. 1988 Nov;6(11):1732–1735. doi: 10.1200/JCO.1988.6.11.1732. [DOI] [PubMed] [Google Scholar]
  69. PALLIS C. A., LOUIS S., MORGAN R. L. Radiation myelopathy. Brain. 1961 Sep;84:460–479. doi: 10.1093/brain/84.3.460. [DOI] [PubMed] [Google Scholar]
  70. Ransom J. L., Novak R. W., Kumar A. P., Hustu H. O., Pratt C. B. Delayed gastrointestinal complications after combined modality therapy of childhood rhabdomyosarcoma. Int J Radiat Oncol Biol Phys. 1979 Aug;5(8):1275–1279. doi: 10.1016/0360-3016(79)90653-9. [DOI] [PubMed] [Google Scholar]
  71. Rossleigh M. A., Smith J., Straus D. J., Engel I. A. Osteonecrosis in patients with malignant lymphoma. A review of 31 cases. Cancer. 1986 Sep 1;58(5):1112–1116. doi: 10.1002/1097-0142(19860901)58:5<1112::aid-cncr2820580522>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  72. Rubin P., Finkelstein J. N., Siemann D. W., Shapiro D. L., Van Houtte P., Penney D. P. Predictive biochemical assays for late radiation effects. Int J Radiat Oncol Biol Phys. 1986 Apr;12(4):469–476. doi: 10.1016/0360-3016(86)90054-4. [DOI] [PubMed] [Google Scholar]
  73. Rubin P., Shapiro D. L., Finklestein J. N., Penney D. P. The early release of surfactant following lung irradiation of alveolar type II cells. Int J Radiat Oncol Biol Phys. 1980 Jan;6(1):75–77. doi: 10.1016/0360-3016(80)90206-0. [DOI] [PubMed] [Google Scholar]
  74. Rubin P., Siemann D. W., Shapiro D. L., Finkelstein J. N., Penney D. P. Surfactant release as an early measure of radiation pneumonitis. Int J Radiat Oncol Biol Phys. 1983 Nov;9(11):1669–1673. doi: 10.1016/0360-3016(83)90420-0. [DOI] [PubMed] [Google Scholar]
  75. Rubin P. The Franz Buschke lecture: late effects of chemotherapy and radiation therapy: a new hypothesis. Int J Radiat Oncol Biol Phys. 1984 Jan;10(1):5–34. doi: 10.1016/0360-3016(84)90408-5. [DOI] [PubMed] [Google Scholar]
  76. Rudolph R., Larson D. L. Etiology and treatment of chemotherapeutic agent extravasation injuries: a review. J Clin Oncol. 1987 Jul;5(7):1116–1126. doi: 10.1200/JCO.1987.5.7.1116. [DOI] [PubMed] [Google Scholar]
  77. STONE D. J., SCHWARTZ M. J., GREEN R. A. Fatal pulmonary insufficiency due to radiation effect upon the lung. Am J Med. 1956 Aug;21(2):211–226. doi: 10.1016/0002-9343(56)90054-7. [DOI] [PubMed] [Google Scholar]
  78. Salazar O. M., Rubin P., Feldstein M. L., Pizzutiello R. High dose radiation therapy in the treatment of malignant gliomas: final report. Int J Radiat Oncol Biol Phys. 1979 Oct;5(10):1733–1740. doi: 10.1016/0360-3016(79)90554-6. [DOI] [PubMed] [Google Scholar]
  79. Schilsky R. L., Barlock A., Ozols R. F. Persistent hypomagnesemia following cisplatin chemotherapy for testicular cancer. Cancer Treat Rep. 1982 Sep;66(9):1767–1769. [PubMed] [Google Scholar]
  80. Schray M. F., Martinez A., Howes A. E., Ballon S. C., Podratz K. C., Sikic B. I., Malkasian G. D. Advanced epithelial ovarian cancer: toxicity of whole abdominal irradiation after operation, combination chemotherapy, and reoperation. Gynecol Oncol. 1986 May;24(1):68–80. doi: 10.1016/0090-8258(86)90009-0. [DOI] [PubMed] [Google Scholar]
  81. Schultheiss T. E., Higgins E. M., El-Mahdi A. M. The latent period in clinical radiation myelopathy. Int J Radiat Oncol Biol Phys. 1984 Jul;10(7):1109–1115. doi: 10.1016/0360-3016(84)90184-6. [DOI] [PubMed] [Google Scholar]
  82. Schultheiss T. E., Stephens L. C., Maor M. H. Analysis of the histopathology of radiation myelopathy. Int J Radiat Oncol Biol Phys. 1988 Jan;14(1):27–32. doi: 10.1016/0360-3016(88)90046-6. [DOI] [PubMed] [Google Scholar]
  83. Sheline G. E., Wara W. M., Smith V. Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys. 1980 Sep;6(9):1215–1228. doi: 10.1016/0360-3016(80)90175-3. [DOI] [PubMed] [Google Scholar]
  84. Sher M. E., Bauer J. Radiation-induced enteropathy. Am J Gastroenterol. 1990 Feb;85(2):121–128. [PubMed] [Google Scholar]
  85. Siegal T., Haim N. Cisplatin-induced peripheral neuropathy. Frequent off-therapy deterioration, demyelinating syndromes, and muscle cramps. Cancer. 1990 Sep 15;66(6):1117–1123. doi: 10.1002/1097-0142(19900915)66:6<1117::aid-cncr2820660607>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  86. Siegel J. P., Puri R. K. Interleukin-2 toxicity. J Clin Oncol. 1991 Apr;9(4):694–704. doi: 10.1200/JCO.1991.9.4.694. [DOI] [PubMed] [Google Scholar]
  87. Sirotnak F. M., Schmid F. A., Samuels L. L., DeGraw J. I. 10-Ethyl-10-deaza-aminopterin: structural design and biochemical, pharmacologic, and antitumor properties. NCI Monogr. 1987;(5):127–131. [PubMed] [Google Scholar]
  88. Steinberg M. E., Brighton C. T., Steinberg D. R., Tooze S. E., Hayken G. D. Treatment of avascular necrosis of the femoral head by a combination of bone grafting, decompression, and electrical stimulation. Clin Orthop Relat Res. 1984 Jun;(186):137–153. [PubMed] [Google Scholar]
  89. Suit H. D., Westgate S. J. Impact of improved local control on survival. Int J Radiat Oncol Biol Phys. 1986 Apr;12(4):453–458. doi: 10.1016/0360-3016(86)90052-0. [DOI] [PubMed] [Google Scholar]
  90. Swan R. W., Fowler W. C., Jr, Boronow R. C. Surgical management of radiation injury to the small intestine. Surg Gynecol Obstet. 1976 Mar;142(3):325–327. [PubMed] [Google Scholar]
  91. Sznol M., Ohnuma T., Holland J. F. Hepatic toxicity of drugs used for hematologic neoplasia. Semin Liver Dis. 1987 Aug;7(3):237–256. doi: 10.1055/s-2008-1040580. [DOI] [PubMed] [Google Scholar]
  92. Takeuchi J., Hanakita J., Abe M., Handa H. Brain necrosis after repeated radiotherapy. Surg Neurol. 1976 Feb;5(2):89–93. [PubMed] [Google Scholar]
  93. Thomas C. R., Jr, Carter I. K., Leslie W. T., Sutton F. Common emergencies in cancer medicine: hematologic and gastrointestinal syndromes. J Natl Med Assoc. 1992 Feb;84(2):165–176. [PMC free article] [PubMed] [Google Scholar]
  94. Thomas C. R., Jr, Dodhia N. Common emergencies in cancer medicine: metabolic syndromes. J Natl Med Assoc. 1991 Sep;83(9):809–818. [PMC free article] [PubMed] [Google Scholar]
  95. Thomas C. R., Jr, Edmondson E. A. Common emergencies in cancer medicine: cardiovascular and neurologic syndromes. J Natl Med Assoc. 1991 Nov;83(11):1001–1017. [PMC free article] [PubMed] [Google Scholar]
  96. Thomas C. R., Jr, Wood L. V., Douglas J. G., Stelzer K. J., Koh W., Panicker R. Common emergencies in cancer medicine: infectious and treatment-related syndromes, Part I. J Natl Med Assoc. 1994 Oct;86(10):765–774. [PMC free article] [PubMed] [Google Scholar]
  97. Tran A., Housset C., Boboc B., Tourani J. M., Carnot F., Berthelot P. Etoposide (VP 16-213) induced hepatitis. Report of three cases following standard-dose treatments. J Hepatol. 1991 Jan;12(1):36–39. doi: 10.1016/0168-8278(91)90905-q. [DOI] [PubMed] [Google Scholar]
  98. Von Hoff D. D., Layard M. W., Basa P., Davis H. L., Jr, Von Hoff A. L., Rozencweig M., Muggia F. M. Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med. 1979 Nov;91(5):710–717. doi: 10.7326/0003-4819-91-5-710. [DOI] [PubMed] [Google Scholar]
  99. Von Hoff D. D., Rozencweig M., Layard M., Slavik M., Muggia F. M. Daunomycin-induced cardiotoxicity in children and adults. A review of 110 cases. Am J Med. 1977 Feb;62(2):200–208. doi: 10.1016/0002-9343(77)90315-1. [DOI] [PubMed] [Google Scholar]
  100. Waldvogel F. A., Medoff G., Swartz M. N. Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects. N Engl J Med. 1970 Jan 22;282(4):198–206. doi: 10.1056/NEJM197001222820406. [DOI] [PubMed] [Google Scholar]
  101. Walker R. W., Rosenblum M. K., Kempin S. J., Christian M. C. Carboplatin-associated thrombotic microangiopathic hemolytic anemia. Cancer. 1989 Sep 1;64(5):1017–1020. doi: 10.1002/1097-0142(19890901)64:5<1017::aid-cncr2820640508>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  102. Wara W. M., Phillips T. L., Margolis L. W., Smith V. Radiation pneumonitis: a new approach to the derivation of time-dose factors. Cancer. 1973 Sep;32(3):547–552. doi: 10.1002/1097-0142(197309)32:3<547::aid-cncr2820320306>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  103. Wara W. M., Phillips T. L., Sheline G. E., Schwade J. G. Radiation tolerance of the spinal cord. Cancer. 1975 Jun;35(6):1558–1562. doi: 10.1002/1097-0142(197506)35:6<1558::aid-cncr2820350613>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  104. Watson P. R., Guthrie T. H., Jr, Caruana R. J. Cisplatin-associated hemolytic-uremic syndrome. Successful treatment with a staphylococcal protein A column. Cancer. 1989 Oct 1;64(7):1400–1403. doi: 10.1002/1097-0142(19891001)64:7<1400::aid-cncr2820640705>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  105. Woo E., Lam K., Yu Y. L., Lee P. W., Huang C. Y. Cerebral radionecrosis: is surgery necessary? J Neurol Neurosurg Psychiatry. 1987 Nov;50(11):1407–1414. doi: 10.1136/jnnp.50.11.1407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Worthington B. S. Diffuse cord enlargement in radiation myelopathy. Clin Radiol. 1979 Jan;30(1):117–119. doi: 10.1016/s0009-9260(79)80062-8. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES